Vivasure gets €16.2mm in Series C funding

15:40 EDT 22 Sep 2016 | Elsevier Business Intelligence

Cardiovascular device maker Vivasure Medical Ltd. raised €16.2mm ($18.3mm) in its Series C financing led by Life Sciences Partners and Evonik Venture Capital, which were joined by Panakès Partners and Fountain Healthcare Partners.

Original Article: Vivasure gets €16.2mm in Series C funding


More From BioPortfolio on "Vivasure gets €16.2mm in Series C funding"

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...